Cholesterol medicine recalled

By WEEK Reporter

Cholesterol medicine recalled

November 23, 2012 Updated Nov 23, 2012 at 11:20 PM CDT

The generic brand of a popular cholesterol medicine is being recalled.  

Ranbaxy Pharmaceuticals has voluntarily recalled a generic brand of Pfizer's Lipitor known as Atorvastatin.
The recall of Atorvastatin will temporarily disrupt supplies in the US market while the company conducts an investigation.
Ranbaxy has not specified a reason at this time for the recall of 10, 20 and 40 milligram doses of the cholesterol fighter. 
Lipitor is one of the world's top selling drugs but lost its patent protection nearly a year ago.
To learn if your prescription is included in this recall, contact your local pharmacy. 

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.